| P2093 | author name string | R Mössner | |
| | S Ugurel | |
| | R Gutzmer | |
| | C Berking | |
| | C Hoeller | |
| | C Loquai | |
| | E Richtig | |
| | J C Hassel | |
| | K C Kähler | |
| | L Zimmer | |
| P2860 | cites work | Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases | Q24309529 |
| | Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 |
| | Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations | Q24632064 |
| | RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF | Q29616828 |
| | Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib | Q38098593 |
| | Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience. | Q38101103 |
| | Dabrafenib therapy for advanced melanoma | Q38164679 |
| | Mechanism and consequences of RAF kinase activation by small-molecule inhibitors | Q38197024 |
| | Neutrophilic Dermatoses in Two Children with Idiopathic Neutropenia: Association with Granulocyte Colony‐Stimulating Factor (G‐CSF) Therapy | Q40592219 |
| | Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib | Q45012388 |
| | Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management | Q50518821 |
| | Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma | Q54372609 |
| | BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis. | Q54376742 |
| | Panniculitis during Dasatinib Therapy for Imatinib-Resistant Chronic Myelogenous Leukemia | Q57748971 |
| P433 | issue | 9 | |
| P304 | page(s) | 1797-1806 | |
| P577 | publication date | 2015-03-06 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of the European Academy of Dermatology and Venereology | Q15760872 |
| P1476 | title | Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature | |
| P478 | volume | 29 | |